The Medicare Transaction Fraud Prevention Act aims to improve the oversight of payments for durable medical equipment and clinical diagnostic laboratory tests under the Medicare program. Its main objective is to test a new method of identifying potentially fraudulent claims using a predictive risk-scoring algorithm. The key provisions of this legislation include the establishment of a pilot program that will run for two years, starting no later than January 1, 2026.